APA-referens

Woyach, J. A., Ruppert, A. S., Heerema, N. A., Peterson, B. L., Gribben, J. G., Morrison, V. A., . . . Byrd, J. C. (2011). Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712. American Society of Clinical Oncology.

Chicago-stil citat

Woyach, Jennifer A., Amy S. Ruppert, Nyla A. Heerema, Bercedis L. Peterson, John G. Gribben, Vicki A. Morrison, Kanti R. Rai, Richard A. Larson, och John C. Byrd. Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712. American Society of Clinical Oncology, 2011.

MLA-referens

Woyach, Jennifer A., et al. Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712. American Society of Clinical Oncology, 2011.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.